While MCC950 treatment inhibited cytosolic Fla-BS-induced IL-1β release by 50-60% across iMGL lines (Figures S2E, F), PI uptake was not decreased by MCC950 in both healthy control and SOD1 ALS lines (Figures S2G, H). The gene discussed is IL1B; the disease is amyotrophic lateral sclerosis.